Literature DB >> 15141080

Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity.

Laurent Poirot1, Christophe Benoist, Diane Mathis.   

Abstract

In both human patients and murine models, the progression from insulitis to diabetes is neither immediate nor inevitable, as illustrated by the innocuous versus destructive infiltrates of BDC2.5 transgenic mice on the nonobese diabetic (NOD) versus C57BL/6.H-2g7 genetic backgrounds. Natural killer (NK)-cell-specific transcripts and the proportion of NK cells were increased in leukocytes from the aggressive BDC2.5/B6.H-2g7 lesions. NK cell participation was also enhanced in the aggressive lesions provoked by CTLA-4 blockade in BDC2.5/NOD mice. In this context, depletion of NK cells significantly inhibited diabetes development. NOD and B6.H-2g7 mice exhibit extensive variation in NK receptor expression, reminiscent of analogous human molecules. NK cells can be important players in type 1 diabetes, a role that was previously underappreciated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15141080      PMCID: PMC419564          DOI: 10.1073/pnas.0402065101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells.

Authors:  Lucie Beaudoin; Véronique Laloux; Jan Novak; Bruno Lucas; Agnès Lehuen
Journal:  Immunity       Date:  2002-12       Impact factor: 31.745

2.  Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro.

Authors:  Sofia E Johansson; Håkan Hall; Jens Björklund; Petter Höglund
Journal:  Int Immunol       Date:  2004-01       Impact factor: 4.823

3.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

4.  Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice.

Authors:  David T Robles; George S Eisenbarth; Natalie J M Dailey; Laurence B Peterson; Linda S Wicker
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

5.  NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen.

Authors:  Ramakrishna Vankayalapati; Peter Klucar; Benjamin Wizel; Stephen E Weis; Buka Samten; Hassan Safi; Homayoun Shams; Peter F Barnes
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

6.  Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity.

Authors:  S Kataoka; J Satoh; H Fujiya; T Toyota; R Suzuki; K Itoh; K Kumagai
Journal:  Diabetes       Date:  1983-03       Impact factor: 9.461

7.  Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes.

Authors:  Emanuela Anastasi; Antonio F Campese; Diana Bellavia; Angela Bulotta; Anna Balestri; Monica Pascucci; Saula Checquolo; Roberto Gradini; Urban Lendahl; Luigi Frati; Alberto Gulino; Umberto Di Mario; Isabella Screpanti
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

8.  Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.

Authors:  A Miyazaki; T Hanafusa; K Yamada; J Miyagawa; H Fujino-Kurihara; H Nakajima; K Nonaka; S Tarui
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

9.  A susceptibility allele from a non-diabetes-prone mouse strain accelerates diabetes in NOD congenic mice.

Authors:  Thomas C Brodnicki; Fiona Quirk; Grant Morahan
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

10.  Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.

Authors:  Robbie B Mailliard; Young-Ik Son; Richard Redlinger; Patrick T Coates; Adam Giermasz; Penelope A Morel; Walter J Storkus; Pawel Kalinski
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.426

View more
  58 in total

Review 1.  Natural killer cell tolerance: control by self or self-control?

Authors:  Baptiste N Jaeger; Eric Vivier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

Review 2.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

3.  Depletion of IL-2 receptor β-positive cells protects from diabetes in non-obese diabetic mice.

Authors:  Hanna Brauner; Håkan T Hall; Malin Flodström-Tullberg; Klas Kärre; Petter Höglund; Sofia Johansson
Journal:  Immunol Cell Biol       Date:  2015-08-05       Impact factor: 5.126

Review 4.  NKG2D in NK and T cell-mediated immunity.

Authors:  Kouetsu Ogasawara; Lewis L Lanier
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

Review 5.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

6.  A selective role of NKG2D in inflammatory and autoimmune diseases.

Authors:  Nadia Guerra; Kathleen Pestal; Tiffany Juarez; Jennifer Beck; Karen Tkach; Lin Wang; David H Raulet
Journal:  Clin Immunol       Date:  2013-09-14       Impact factor: 3.969

Review 7.  Regulatory NK-cell functions in inflammation and autoimmunity.

Authors:  Anna Lünemann; Jan D Lünemann; Christian Münz
Journal:  Mol Med       Date:  2009-05-11       Impact factor: 6.354

8.  NKG2D-RAE-1 receptor-ligand variation does not account for the NK cell defect in nonobese diabetic mice.

Authors:  Lisa M Maier; Sarah K Howlett; Kara M Rainbow; Jan Clark; Joanna M M Howson; John A Todd; Linda S Wicker
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

9.  Interleukin-21 is required for the development of type 1 diabetes in NOD mice.

Authors:  Andrew P R Sutherland; Tom Van Belle; Andrea L Wurster; Akira Suto; Monia Michaud; Dorothy Zhang; Michael J Grusby; Matthias von Herrath
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

10.  Inferring differentiation pathways from gene expression.

Authors:  Ivan G Costa; Stefan Roepcke; Christoph Hafemeister; Alexander Schliep
Journal:  Bioinformatics       Date:  2008-07-01       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.